Structural Characterisation of Islet Amyloid Polypeptide Fibrils

Journal of Molecular Biology

Volumn 335, Issue 5, 2004, Pages 1279-1288

  Makin, O Sumner ^a   Serpell, Louise C ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Amylin; Amyloid; Electron microscopy; Fibre diffraction; IAPP

Indexed keywords

AMYLIN;

ARTICLE; BETA SHEET; CRYOELECTRON MICROSCOPY; ELECTRON DIFFRACTION; ELECTRON MICROSCOPY; HYDROGEN BOND; MOLECULAR BIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

EID: 0347284249     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.11.048     Document Type: Article

References (45)

1. Clark A., Edwards C., Ostle L., Sutton R., Rothbard J. Localization of islet amyloid peptide in lipofuscin bodies and secretory granules of human b-cells and in islets of type 2 diabetic subjects. Cell Tissue Res. 257:1989;179-185.
2. Sanke T., Hanabusa T., Nakano Y., Oki C., Okai K., Nishimura S., et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34:1991;129-132.
3. Goldsbury C., Goldie K., Pellaud J., Seelig J., Frey P., Muller S., et al. Amyloid fibril formation from full-length and fragments of amylin. J. Struct. Biol. 130:2000;352-362.
4. Higham C., Jaikaran E., Fraser P., Gross M., Clark A. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Letters. 470:2000;55-60.
5. Clark A., Cooper G., Lewis C., Morris J., Willis A., Reid K., Turner R. Islet amyloid formed from diabetes associated peptide may be pathogenic in type-2 diabetes. Lancet. 2:1987;231-234.
6. Westermark P., Wernstadt C., Wilander E., Hayden D., O' Brien T., Johnson K. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in the islet cells. Proc. Natl Acad. Sci. USA. 84:1987;3881-3885.
7. Westermark P., Engstrom U., Johnson K., Westermark G., Betsholtz C. Islet amyloid polypeptide: pinpointing amino-acid residues linked to amyloid fibril formation. Proc. Natl Acad. Sci. USA. 87:1990;5036-5040.
8. Charge S., de Koning E., Clark A. Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochemistry. 34:1995;14588-14593.
9. Nilsson M., Raleigh D. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 294:1999;1375-1385.
10. Jaikaran E., Higham C., Serpell L., Zurdo J., Gross M., Clark A., Fraser P. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308:2001;515-525.
11. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287:1999;781-796.
12. Puchtler H., Sweat F., Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10:1961;355-364.
13. Lorenzo A., Razzaboni B., Weir G., Yankner B. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
14. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA. 91:1994;12243-12247.
15. Rochet J., Lansbury P.J. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:2000;60-68.
16. Sunde M., Serpell L., Bartlam M., Fraser P., Pepys M., Blake C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273:1997;729-739.
17. Geddes A.J., Parker K.D., Atkins E.D.T., Beighton E. Cross β conformation in protein. J. Mol. Biol. 32:1968;343-358.
18. Eanes E.D., Glenner G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16:1968;673-677.
19. Blake C., Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-helix. Structure. 4:1996;989-998.
20. Serpell L., Smith J. Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol. 299:2000;225-231.
21. Serpell L.C., Sunde M., Fraser P.E., Luther P.K., Morris E., Sandgren O., et al. The examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254:1995;113-118.
22. Serpell L., Sunde M., Benson M., Tennent G., Pepys M., Fraser P. The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300:2000;1033-1039.
23. Goldsbury C.S., Cooper G.J.S., Goldie K.N., Muller S.A., Saafi E.L., Gruijters W.T.M., Misur M.P. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119:1997;17-27.
24. MacPhee C., Dobson C. Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin. J. Mol. Biol. 297:2000;1203-1215.
25. Jimenez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C., Sunde M., Saibil H. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18:1999;815-821.
26. Azriel R., Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276:2001;34156-34161.
27. Moriarty D., Raleigh D. Effects of sequential proline substitutions on amyloid formation by human amylin 20-29. Biochemistry. 38:1999;1811-1818.
28. Tenidis K., Waldner M., Bernhagen J., Fischle W., Bergmann M., Weber M., et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295:2000;1055-1071.
29. Betsholtz C., Christmanson L., Engstrom U., Rorsman F., Jordan K., O'Brien T., et al. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes. 39:1990;118-122.
30. Glenner G., Eanes E., Wiley C. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochim. Biophys. Res. Commun. 155:1988;608-614.
31. Green J., Goldsbury C., Mini T., Sunderji S., Frey P., Kistler J., et al. Full-length rat amylin forms fibrils following substitution of single residues from human amylin. J. Mol. Biol. 326:2003;1147-1156.
32. Mazor Y., Gilead S., Benhar I., Gazit E. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J. Mol. Biol. 322:2002;1013-1024.
33. Scrocchi L.A., Ha K., Chen Y., Wu L., Wang F., Fraser P.E. Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. J. Struct. Biol. 141:2003;218-227.
34. Serpell L.C., Blake C.C.F., Fraser P.E. Molecular structure of a fibrillar Alzheimer's Ab fragment. Biochemistry. 39:2000;13269-13275.
35. Serpell L.C., Berriman J., Jakes R., Goedert M., Crowther R.A. Fiber diffraction of synthetic a-synuclein filaments shows amyloid-like cross-b conformation. Proc. Natl Acad. Sci. USA. 97:2000;4897-4902.
36. Berriman J., Serpell L.C., Oberg K.A., Fink A.L., Goedert M., Crowther R.A. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc. Natl Acad. Sci. USA. 100:2003;9034-9038.
37. Smith J.M. XIMDISP - a visualization tool to aid in structure determination from electron micrograph images. J. Struct. Biol. 125:1999;223-228.
38. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., Tycko R. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA. 99:2002;16742-16747.
39. Der-Sarkissian A., Jao C.C., Chen J., Langen R. Structural organisation of alpha-synuclein studied by site-directed spin labelling. J. Biol. Chem. 278:2003;37530-37535.
40. Griffiths J.M., Ashburn T.T., Auger M., Costa P.R., Griffin R.G., Lansbury P.T. Rotational resonance solid state NMR elucidates a structural model of pancreatic amyloid. J. Am. Chem. Soc. 117:1995;3539-3546.
41. Benzinger T.L.S., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., Meredith S.C. Propagating structure of Alzheimer's b-amyloid (10-35) is parallel b-sheet with residues in exact register. Proc. Natl Acad. Sci. USA. 95:1998;13407-13412.
42. Sikorski P., Atkins E.D.T., Serpell L.C. Structure and textures of fibrous crystals of the Abeta (11-25) fragment from Alzheimer's Abeta amyloid protein. Structure. 11:2003;915-926.
43. Jaikaran E., Clark A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta. 1537:2001;179-203.
44. Padrick S.B., Miranker A.D. Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway. J. Mol. Biol. 308:2001;783-794.
45. Crowther R.A., Henderson R., Smith J. MRC image processing programs. J. Struct. Biol. 116:1996;9-16.